Filters
12 products
HHC vapes were one of the fastest-growing cannabinoid product categories in Europe between 2022 and 2024. A wave of national bans across the EU and the placement of HHC into Schedule II of the UN Single Convention in December 2025 ended the legal market in every member state. Anyone trying to buy an HHC vape today will not find a legal product. The closest legal alternative with a comparable effect profile is HHZ. This page explains what HHC vapes were, how the legal situation evolved across Europe, and which option is available to buy now.
An HHC vape is a vaporizer that delivers hexahydrocannabinol through inhalation. The active compound sits in a liquid carrier, usually a mix of MCT or VG with terpenes for flavor. When the user draws on the device, a small heating element vaporizes the liquid and the cannabinoid is absorbed through the lungs. Three formats existed: disposable pens with built-in battery and tank, refillable cartridges that screwed onto a 510-thread battery, and standalone e-liquids for open tank systems. Concentrations of HHC ranged from around 70 percent in mid-tier products to 95 percent in high-potency variants.
HHC binds to the same CB1 and CB2 receptors as THC, but as a partial agonist with slightly different binding affinity. The result is a psychoactive effect that users described as milder than THC, with stronger physical relaxation and less of the racing-thoughts profile that pure THC can produce. Onset through inhalation was fast. Most users reported a noticeable effect within two to five puffs and a peak after about ten to fifteen minutes. Duration was typically one to two hours, depending on dose, concentration, and individual tolerance. Reported side effects matched those known from cannabis use: dry mouth, red eyes, increased appetite, and in higher doses dizziness or anxiety.
The HHC product space included several derivatives, each with a different molecular structure and reported potency. HHC-P (hexahydrocannabiphorol) carries a longer side chain and was marketed as significantly more potent than baseline HHC. HHC-O (HHC acetate) is an acetylated form that converts back to HHC during metabolism. HHC-A describes acid and aldehyde-related variants. 10-OH-HHC and 10-OH-HHCP are oxidized derivatives that emerged in late 2024 as the European market searched for compounds outside the immediate scope of the early national bans. Important: all of these variants are covered by the same legal classification as HHC itself. After the UN Schedule II decision in December 2025, none of them may be legally sold in the European Union.
Three product types defined the HHC vape category. HHC vape pens were disposable, ready-to-use devices designed for entry-level users. They came pre-charged and pre-filled, typically with one to two milliliters of liquid. HHC vape cartridges were refillable or replaceable tanks that connected to a separate 510-thread battery and offered better cost efficiency for regular users. HHC vape liquids were sold in dropper bottles for filling open tank systems and gave the user more control over dose and device. Across all three formats, the active mechanism was identical: rapid pulmonary absorption of the cannabinoid.
No. The legal situation across Europe is unambiguous as of 2026. The first national restriction came in Austria in late 2022, when HHC was classified under the national framework for new psychoactive substances. Over the following two years, most EU member states followed in waves. France, Finland, Estonia, Belgium, Sweden, Denmark, the Baltic states, Italy, the Netherlands, Poland, and Germany introduced bans or controlled-substance classifications for HHC between 2023 and 2024. By the end of 2024, the substance was no longer legally available in any major European market. The decisive shift came in December 2025, when the UN Commission on Narcotic Drugs placed HHC and its derivatives into Schedule II of the Single Convention on Narcotic Drugs. This decision obliges all signatory states to treat HHC as a controlled substance and effectively ends the legal market for HHC vapes worldwide. A detailed country-by-country overview is available in our article on the HHC legal status around the world. The European Union Drugs Agency publishes ongoing market reports on HHC and related substances at the EUDA.
HHC vapes are no longer available to buy through legal retail or online channels anywhere in the EU. Offers from third countries do not solve the problem, because import and possession remain regulated under national law and customs intercepts are common. The cannabinoid market has responded with HHZ, a structurally different compound that is not covered by the HHC classification and is currently legal to place on the market in the European Union. Users describe the HHZ effect profile as close to HHC: physically relaxing, with a clear head space, and generally less intense than pure THC. HHZ vapes use the same delivery formats that defined the HHC era, including disposable pens, replaceable cartridges, and refill liquids. Anyone looking for the closest legal option to buy will find current products in the HHZ Vape Collection. The full HHZ assortment, including flowers, oils, and edibles, is listed under all HHZ products.
